Andrea Braun
No más puestos en curso
Perfil
Andrea Braun worked as Head of EU Regulatory Affairs at Roche Group, Head of Regulatory & Quality Affairs at Auris Medical Holding AG, Head of Global Regulatory Affairs at Alvotech GmbH, and Head of Regulatory & Quality Affairs at Altamira Therapeutics Ltd.
She holds a doctorate degree from the University of Basel.
Antiguos cargos conocidos de Andrea Braun.
Empresas | Cargo | Fin |
---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Consejero General | - |
Alvotech GmbH | Consejero General | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Corporate Officer/Principal | - |
Formación de Andrea Braun.
University of Basel | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Empresas privadas | 3 |
---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Alvotech GmbH |
- Bolsa de valores
- Insiders
- Andrea Braun